Colorectal Cancer News
New Meta-Study: Chemo Delays Increase Mortality Risk
In a new meta-study announced at the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Conference, recent research shows that delays in adjuvant chemotherapy for those with colon cancer translate into almost 2,500 potentially avoidable deaths per year. The goal of the study was the quantify the relationship between the administration of treatment and survival. Data shows that even a delay of four weeks can increase the mortality risk. By delaying eight weeks, the risk increased to 12%, and by twelve weeks, the risk increased to nearly 25%.
The study cites two reasons for the delay in treatment. First were patient-related, and included postoperative complications and variations in recovery. Secondly, the study cited logistical issues, including institution-specific delays and inefficiencies. The study shows the importance of health care professionals and centers efficiently presenting – and beginning – treatment options for colon cancer patients.
The data was collected from studies published from 1975 to 2009 and relevant abstracts from the 2007 to 2009 meetings of the American Society of Clinical Oncology.
Bankhead, Charles. ASCO GI: Chemo Delay Puts Lives at Risk in Colon CA.MedPage Today. 2011 January 24.